BREAKING: Lilly to buy ImClone for $6B
Eli Lilly and Co. this morning announced that it has agreed to buy biotechnology company ImClone Systems Inc. for more than $6 billion, a deal that expands Lilly’s pipeline of cancer treatments. Indianapolis-based Lilly said it will pay $70 per share for New York-based ImClone. “We really do create an oncology powerhouse,” Lilly CEO John Lechleiter said this […]